With expertise in optical sensors and bio signal analysis, the VitalSines team has developed their first product, iHeart, a fingertip device and mobile app that determines a user's internal age by measuring Aortic Stiffness. This metric is a proven indicator of the risk of heart disease, brain disease, and overall mortality, but it can be reversed with positive lifestyle choices. iHeart has been successfully sold for three years, with over 10,000 users across 65 countries and nearly $1M in revenue. Building on user feedback, the team is now working on a more affordable device with additional features like blood pressure measurement without a cuff and ECG functionality. The new hardware will be paired with an AI health coaching application available through a subscription model. The development of this next-generation product is almost complete, and it is set to ship in Q3 2019. iHeart's mission is to provide consumers with easily accessible and cost-effective health monitoring products that offer a revolutionary understanding of the human body. Their flagship product, iHeart Internal Age, offers a 30-second assessment of a user's internal age by measuring Aortic Stiffness, a scientifically proven marker of heart health, cognitive decline, dementia, and overall mortality. Previously, this information was only obtainable through expensive medical devices, but iHeart provides the same results for less than $200. The passionate iHeart team aims to educate users about the impact of their daily actions on their internal health and lifespan, helping them achieve optimal well-being.